These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16061266)

  • 21. Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.
    Yen PJ; Herschhorn A; Haim H; Salas I; Gu C; Sodroski J; Gabuzda D
    J Virol; 2014 May; 88(9):5014-28. PubMed ID: 24554659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Truncating the gp41 Cytoplasmic Tail of Simian Immunodeficiency Virus Decreases Sensitivity to Neutralizing Antibodies without Increasing the Envelope Content of Virions.
    White E; Wu F; Chertova E; Bess J; Roser JD; Lifson JD; Hirsch VM
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins.
    Hill CM; Kwon D; Jones M; Davis CB; Marmon S; Daugherty BL; DeMartino JA; Springer MS; Unutmaz D; Littman DR
    Virology; 1998 Sep; 248(2):357-71. PubMed ID: 9721244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
    Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
    J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro.
    Overholser ED; Coleman GD; Bennett JL; Casaday RJ; Zink MC; Barber SA; Clements JE
    J Virol; 2003 Jun; 77(12):6855-66. PubMed ID: 12768005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition.
    Rudensey LM; Kimata JT; Long EM; Chackerian B; Overbaugh J
    J Virol; 1998 Jan; 72(1):209-17. PubMed ID: 9420217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains.
    Edinger AL; Blanpain C; Kunstman KJ; Wolinsky SM; Parmentier M; Doms RW
    J Virol; 1999 May; 73(5):4062-73. PubMed ID: 10196302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry.
    Kirchhoff F; Pöhlmann S; Hamacher M; Means RE; Kraus T; Uberla K; Di Marzio P
    J Virol; 1997 Sep; 71(9):6509-16. PubMed ID: 9261370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.
    Means RE; Matthews T; Hoxie JA; Malim MH; Kodama T; Desrosiers RC
    J Virol; 2001 Apr; 75(8):3903-15. PubMed ID: 11264379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of plasma viremia and antibody responses in macaques inoculated with envelope variants of single-cycle simian immunodeficiency virus differing in infectivity and cellular tropism.
    DeGottardi MQ; Lew SK; Piatak M; Jia B; Feng Y; Lee SJ; Brenchley JM; Douek DC; Kodama T; Lifson JD; Evans DT
    J Virol; 2008 Jan; 82(1):321-34. PubMed ID: 17942538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains.
    Edinger AL; Amedee A; Miller K; Doranz BJ; Endres M; Sharron M; Samson M; Lu ZH; Clements JE; Murphey-Corb M; Peiper SC; Parmentier M; Broder CC; Doms RW
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4005-10. PubMed ID: 9108095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells.
    Schenten D; Marcon L; Karlsson GB; Parolin C; Kodama T; Gerard N; Sodroski J
    J Virol; 1999 Jul; 73(7):5373-80. PubMed ID: 10364284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.
    Zhang Y; Lou B; Lal RB; Gettie A; Marx PA; Moore JP
    J Virol; 2000 Aug; 74(15):6893-910. PubMed ID: 10888629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo.
    Reeves JD; Hibbitts S; Simmons G; McKnight A; Azevedo-Pereira JM; Moniz-Pereira J; Clapham PR
    J Virol; 1999 Sep; 73(9):7795-804. PubMed ID: 10438870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L.
    Pal R; Taylor B; Foulke JS; Woodward R; Merges M; Praschunus R; Gibson A; Reitz M
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):300-7. PubMed ID: 12843740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
    König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
    J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors.
    Riddick NE; Wu F; Matsuda K; Whitted S; Ourmanov I; Goldstein S; Goeken RM; Plishka RJ; Buckler-White A; Brenchley JM; Hirsch VM
    J Virol; 2015 Dec; 90(5):2316-31. PubMed ID: 26656714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simian Immunodeficiency Virus SIVmac239, but Not SIVmac316, Binds and Utilizes Human CD4 More Efficiently than Rhesus CD4.
    Fellinger CH; Gardner MR; Bailey CC; Farzan M
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus.
    Yuste E; Johnson W; Pavlakis GN; Desrosiers RC
    J Virol; 2005 Oct; 79(19):12455-63. PubMed ID: 16160173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.